Ernexa Therapeutics Stock Rises After Study Validates

Ernexa Therapeutics Inc. shares rose 7.43% to $6.51 following the release of positive results from an…

Veradermics’ Hair Loss Drug Shows Positive Phase 2 Results

Veradermics reported positive results from its Phase 2 study of VDPHL01, an oral treatment for female…

Royalty Pharma Opens Hong Kong Office Amid Biotech Surge

Royalty Pharma, the world's largest buyer of biopharmaceutical royalties, has established its first Asia-Pacific base in…